Mise à jour sur le statut réglementaire de la toxine botulique de type A d’Ipsen aux Etats-Unis

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021